Advertisement
The U.S. Food and Drug Administration investigation into the safety of codeine use by children

FDA Investigation Linked to Drop in Codeine Rx for Children

0
But 1 in 20 patients undergoing tonsillectomy and/or adenoidectomy still prescribed codeine
Insurance coverage differences account for about half of the disparity in survival rates between black and white patients aged 18 to 64 years with colorectal cancer

Insurance Underlies Black-White Survival Disparity in CRC

0
54 percent of excess risk of death in black colorectal cancer patients accounted for by insurance matching
The first drug in the United States with a digital ingestion tracking system has been approved by the U.S. Food and Drug Administration.

FDA Approves Drug With Digital Ingestion Tracking System

0
Aripiprazole tablets have embedded sensors so patients, physicians can track medication ingestion
Psychostimulant use during pregnancy is associated with a small increased relative risk of preeclampsia and preterm birth

Psychostimulant Use Tied to Placental Complications

0
Small increased relative risk of preeclampsia, preterm birth; absolute risk increases are small
HIV-positive individuals treated with combination antiretroviral therapy have poorer neuropsychological test scores than controls but no significant neuropsychological decline over time

Poorer Neuropsychological Test Scores for HIV-Positive

0
No significant neuropsychological decline during two-year period with combination antiretroviral therapy
A 250-μg peanut patch produces a significant treatment response in peanut-allergic patients treated for a year

Peanut Patch Found Safe, Effective for Treating Allergies

0
250-μg patch produces significant treatment response compared with placebo after 12 months
For patients who have experienced an atherosclerotic cardiovascular disease event

AHA: Statins Cut Risk of MACE in Patients With ASCVD Event

0
Reduced frequency of MACE for patients receiving statins, especially high-intensity statins
Although initiation of extended-release naltrexone (XR-NTX) may be more difficult

XR Naltrexone, Sublingual BUP-NX Deemed Equally Effective

0
Difficulty initiating XR-NTX accounts for difference in relapse rates in intent-to-treat population
Despite increases in HbA1c testing and awareness

In 2007-2014, Glycemic Control Plateaued in Diabetes Patients

0
But significant improvements in HbA1c testing and awareness seen, except in those aged 20 to 44
The addition of azithromycin to cephalosporin for cesarean delivery infection prophylaxis is cost-effective and leads to better maternal outcomes

Drug Combination Cost-Effective for Cesarean Prophylaxis

0
Improved maternal outcomes when azithromycin is added to cephalosporin for infection prophylaxis